Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan M Schwab

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Plos Pathogens|May 10, 2014
Timed action of IL-27 protects from immunopathology while preserving defense in influenzaFrancesca Diane M Liu, Elisabeth E Kenngott, Micha F Schröter, et al.
Neurology|October 27, 2012
Neurofascin as a target for autoantibodies in peripheral neuropathiesJudy King Man Ng, Joachim Malotka, Naoto Kawakami, et al.
Nature Neuroscience|September 19, 2017
Spinal cord injury-induced immunodeficiency is mediated by a sympathetic-neuroendocrine adrenal reflexHarald Prüss, Andrea Tedeschi, Aude Thiriot, et al.
BMC Neurology|September 14, 2016
Natural Killer (NK) Cell Functionality after human Spinal Cord Injury (SCI): protocol of a prospective, longitudinal studyInês Laginha, Marcel A Kopp, Claudia Druschel, et al.
Experimental Neurology|November 10, 2024
Enhancing data standards to advance translation in spinal cord injuryVanessa K Noonan, Suzanne Humphreys, Fin Biering-Sørensen, et al.
Cell|May 11, 2024
Spinal projecting neurons in rostral ventromedial medulla co-regulate motor and sympathetic toneZicong Zhang, Junfeng Su, Jing Tang, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 5, 2023
Lesional Antibody Synthesis and Complement Deposition Associate With De Novo Antineuronal Antibody Synthesis After Spinal Cord InjuryJan M Schwab, Carmen Haider, Marcel A Kopp, et al.
Spinal Cord|April 28, 2018
Lower extremity outcome measures: considerations for clinical trials in spinal cord injuryMarc Bolliger, Andrew R Blight, Edelle C Field-Fote, et al.
Scientific Reports|January 10, 2026
T-cell biomarkers improve urinary tract infection risk stratification beyond clinical characteristics after acute traumatic spinal cord injuryOliver Schweizerhof, Christian Meisel, Christian Blex, et al.
Spinal Cord|December 30, 2017
Considerations and recommendations for selection and utilization of upper extremity clinical outcome assessments in human spinal cord injury trialsLinda A T Jones, Anne Bryden, Tracey L Wheeler, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Plos Pathogens|May 10, 2014
Timed action of IL-27 protects from immunopathology while preserving defense in influenzaFrancesca Diane M Liu, Elisabeth E Kenngott, Micha F Schröter, et al.
Neurology|October 27, 2012
Neurofascin as a target for autoantibodies in peripheral neuropathiesJudy King Man Ng, Joachim Malotka, Naoto Kawakami, et al.
Nature Neuroscience|September 19, 2017
Spinal cord injury-induced immunodeficiency is mediated by a sympathetic-neuroendocrine adrenal reflexHarald Prüss, Andrea Tedeschi, Aude Thiriot, et al.
BMC Neurology|September 14, 2016
Natural Killer (NK) Cell Functionality after human Spinal Cord Injury (SCI): protocol of a prospective, longitudinal studyInês Laginha, Marcel A Kopp, Claudia Druschel, et al.
Experimental Neurology|November 10, 2024
Enhancing data standards to advance translation in spinal cord injuryVanessa K Noonan, Suzanne Humphreys, Fin Biering-Sørensen, et al.
Cell|May 11, 2024
Spinal projecting neurons in rostral ventromedial medulla co-regulate motor and sympathetic toneZicong Zhang, Junfeng Su, Jing Tang, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 5, 2023
Lesional Antibody Synthesis and Complement Deposition Associate With De Novo Antineuronal Antibody Synthesis After Spinal Cord InjuryJan M Schwab, Carmen Haider, Marcel A Kopp, et al.
Spinal Cord|April 28, 2018
Lower extremity outcome measures: considerations for clinical trials in spinal cord injuryMarc Bolliger, Andrew R Blight, Edelle C Field-Fote, et al.
Scientific Reports|January 10, 2026
T-cell biomarkers improve urinary tract infection risk stratification beyond clinical characteristics after acute traumatic spinal cord injuryOliver Schweizerhof, Christian Meisel, Christian Blex, et al.
Spinal Cord|December 30, 2017
Considerations and recommendations for selection and utilization of upper extremity clinical outcome assessments in human spinal cord injury trialsLinda A T Jones, Anne Bryden, Tracey L Wheeler, et al.
Pageof 12